Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I.

Li LN, Zhang HD, Zhi R, Yuan SJ.

Br J Pharmacol. 2011 Jan;162(2):349-64. doi: 10.1111/j.1476-5381.2010.01042.x.

2.
3.

Mistletoe lectin-I augments antiproliferative effects of the PPARgamma agonist rosiglitazone on human malignant melanoma cells.

Freudlsperger C, Dahl A, Hoffmann J, Reinert S, Schumacher U.

Phytother Res. 2010 Sep;24(9):1354-8. doi: 10.1002/ptr.3122.

PMID:
20812278
4.

Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.

Zarković N, Kalisnik T, Loncarić I, Borović S, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S.

Cancer Biother Radiopharm. 1998 Apr;13(2):121-31.

PMID:
10850348
5.

[Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].

Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):598-604. doi: 10.3760/cma.j.issn.1007-3418.2012.08.012. Chinese.

PMID:
23207154
7.

MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.

Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, Liu L, Jia D, Tian Q, Wu J, Ye Y, Wang Q, Long Z, Zhou Y, Du C, He X, Shi Y.

Clin Cancer Res. 2011 Dec 15;17(24):7574-83. doi: 10.1158/1078-0432.CCR-11-1714. Epub 2011 Oct 12. Erratum in: Clin Cancer Res. 2012 Aug 1;18(15)4216.

8.

Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer models.

Chu ES, Sze SC, Cheung HP, Wong KL, Liu Q, Ng TB, Tong Y.

J Ethnopharmacol. 2011 Sep 1;137(1):403-13. doi: 10.1016/j.jep.2011.05.035. Epub 2011 Jun 6.

PMID:
21669277
9.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

10.

Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.

Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D.

BMC Cancer. 2012 Jan 20;12:29. doi: 10.1186/1471-2407-12-29.

11.

miRNA regulation of cytotoxic effects in mouse Sertoli cells exposed to nonylphenol.

Choi JS, Oh JH, Park HJ, Choi MS, Park SM, Kang SJ, Oh MJ, Kim SJ, Hwang SY, Yoon S.

Reprod Biol Endocrinol. 2011 Sep 14;9:126. doi: 10.1186/1477-7827-9-126.

12.

Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma.

Pryme IF, Bardocz S, Pusztai A, Ewen SW.

Histol Histopathol. 2002 Jan;17(1):261-71. Review.

PMID:
11820217
14.
15.
16.

[Ingredients of mistletoe (Viscum album L.) as potential drugs].

Franz H.

Pharmazie. 1985 Feb;40(2):97-104. German. No abstract available.

PMID:
3889937
17.

Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.

Bocci V.

J Biol Regul Homeost Agents. 1993 Jan-Mar;7(1):1-6. Review.

PMID:
8346712
18.

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.

Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P.

Cancer Chemother Pharmacol. 2013 May;71(5):1159-71. doi: 10.1007/s00280-013-2108-y. Epub 2013 Feb 20.

PMID:
23423488
19.

Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.

Weber K, Mengs U, Schwarz T, Hajto T, Hostanska K, Allen TR, Weyhenmeyer R, Lentzen H.

Arzneimittelforschung. 1998 May;48(5):497-502.

PMID:
9638318
20.

The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.

Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2321-32. doi: 10.1016/j.biocel.2012.08.006. Epub 2012 Aug 10.

PMID:
22903020
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk